Preoperative chemotherapy significantly increased overall survival in patients with liver-limited metastasis from gastric cancer who underwent hepatectomy, compared to upfront surgery. Patients who exhibited a partial response to preoperative chemotherapy had better outcomes than those with stable or progressive disease. The preoperative chemotherapy group also had a higher chance of undergoing surgical resection for recurrent tumors. These results suggest that preoperative chemotherapy can be recommended for patients with liver-limited metastasis from gastric cancer.
Journal Article by Hirose Y, Aizawa M (…) Nakagawa S et 8 al. in Ann Surg Oncol
© 2024. Society of Surgical Oncology.